CompletedNCT04280367
Official study titleChildhood Learning and Executive Function Disorders and Risk of Psychosis in the Adulthood
This study has finished and is no longer accepting participants.
In FranceSchizophreniaObservational studyAges 15–30
- Countries
- France
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CompletedNCT07418255
This study has finished and is no longer accepting participants.
In FranceAnxietyObservational studyAges 18+
- Countries
- France
- Sponsor
- Université de Reims Champagne-Ardenne
CompletedNCT03094260
Official study titleInterest of Light Therapy in the Treatment of Binge Eating Disorder: Prospective Controlled Randomized Double-blind Trial
This study has finished and is no longer accepting participants.
In FranceEating disordersDevice studyAges 18–55
- Countries
- France
- Sponsor
- Hospices Civils de Lyon
Active Not RecruitingNCT07199179
This study is no longer accepting new participants.
In FranceDepressionObservational studyAges 18–64
- Countries
- France
- Sponsor
- University Hospital, Montpellier
CompletedNCT02334956
This study has finished and is no longer accepting participants.
In FranceAddictionInterventional studyAges 18–64
- Countries
- France
- Sponsor
- University Hospital, Bordeaux
TerminatedNCT03432000
Official study titleStudy of the Links Between Perception of Temporal Order Judgment and Causality in Schizophrenic Spectrum Disorders
This study ended early.
In FranceSchizophreniaInterventional studyAges 18–45
- Countries
- France
- Sponsor
- Hôpital le Vinatier
CompletedNCT05861375
Official study titleAssessment of Liver Damage Using the Fibroscan in Patients With Anorexia Nervosa
This study has finished and is no longer accepting participants.
In FranceEating disordersObservational studyAges 15+
- Countries
- France
- Sponsor
- Nantes University Hospital
CompletedNCT00216671
Official study titleEarly Versus Late Initiation of Treatment With Risperdal Consta in Subjects With Schizophrenia After an Acute Episode
This study has finished and is no longer accepting participants.
In FranceSchizophreniaMedication studyAges 18–65
- Countries
- France, United Kingdom, Switzerland, + 7 others
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
CompletedNCT01271842
This study has finished and is no longer accepting participants.
In FrancePTSDObservational studyAges 18–65
- Countries
- France
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
CompletedNCT05520047
Official study titleAssessment and Prognostic Factors of Long-term Quality of Life of Patients Hospitalized With Severe COVID-19 and Their Relatives
This study has finished and is no longer accepting participants.
In FrancePTSDObservational studyAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier Régional Metz-Thionville
CompletedNCT00190684
What is this study about?Researchers studied atomoxetine, tracking side effects to assess long-term safety in people with ADHD.
This study has finished and is no longer accepting participants.
In FranceADHDMedication studyAges 6–18
- Countries
- France, United States, Australia, + 10 others
- Sponsor
- Eli Lilly and Company
CompletedEUCTR 2015-002658-11
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FranceDepressionHistorical research record
- Countries
- France, United Kingdom, Belgium, + 8 others
- Sponsor
- H. Lundbeck A/S